← Leaderboards
Chiang Jia Li
Boston Biomedical, Inc.
$2,876,444
Attributed
$2,876,444
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $485.5K · FY2008–16$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,876,444 · 4
By mechanism
R01$1,641,429 · 1
R43$1,235,015 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mammalian Cell”
- James C. Paulson · Scripps Research Institute$85,461,022
- David Heimbrook · Leidos Biomedical Research, Inc.$66,413,153
- Kc Kent Lloyd · University Of California At Davis$54,337,173
- Hongkui Zeng · Allen Institute$46,795,419
- Andrew P McMahon · Harvard University (Medical School)$41,437,838
- Chuan He · University Of Chicago$34,870,423
Research focus
Mammalian CellIn VitroBaseGene SilencingDesignRna InterferenceTechnologyMediatingCellsGenesIn VivoBeta CateninAttenuatedSpecificityMedicineHuman DiseaseMeetingsGene FunctionGeneticGene TargetingEpigenetic ProcessCommunicable DiseasesImmune ResponseProperty
Grant awards (8)
Transkingdom Gene Silencing$330,600
R01 · FY2016 · GM · contact PI
Transkingdom Gene Silencing$330,600
R01 · FY2015 · GM · contact PI
Transkingdom Gene Silencing$330,600
R01 · FY2014 · GM · contact PI
Transkingdom Gene Silencing$319,029
R01 · FY2013 · GM · contact PI
Transkingdom Gene Silencing$330,600
R01 · FY2012 · GM · contact PI
Development of Specific Gene Silencing Methods and Reagents$312,194
R43 · FY2011 · GM · contact PI
Development of aiRNA technology$485,527
R43 · FY2010 · GM · contact PI
Cancer targeted therapy through bacterial RNAi$437,294
R43 · FY2008 · CA · contact PI